Elizabeth Holmes is drawing audiences back to The Dropout, and the reason to revisit it goes beyond recognizing the black turtleneck. Renewed attention surrounding You Can See Everything has returned the television drama to the conversation. What makes it rewarding is its examination of a more uncomfortable question: how does a roomful of people learn to treat conviction as evidence?
Created by Elizabeth Meriwether, the 2022 series stars Amanda Seyfried as Holmes and Naveen Andrews as Sunny Balwani. Its story follows Holmes from Stanford into the rise and unraveling of Theranos. My judgment is that its strongest passages make a familiar corporate scandal feel frighteningly intimate. Every promise requires someone else to keep believing, and every unanswered question makes that belief more expensive.
Spoilers follow for The Dropout, including its portrayal of deception at Theranos and the employees who challenge the company. The character interpretations below concern the dramatization; private scenes and dialogue should not be treated as transcripts of real events.
A founder who learns to perform certainty
Seyfried’s most interesting choice is to make authority look effortful. Her Elizabeth does not begin as an effortlessly commanding executive. She studies the appearance of success and works toward reproducing it. The lowered voice and tightly controlled presentation become tools for getting other people to see the person she intends to become.
That effort is concentrated in a short line: “This is an inspiring step forward.” Repeated as vocal practice, it becomes strangely detached from achievement. What matters in the moment is whether the sentence sounds convincing. The scene gives the series a miniature version of its central conflict: a declaration of progress can be perfected while the underlying work remains unfinished.
The performance invites us to notice the distance between intention and expression. Elizabeth’s determination can seem almost painfully exposed even when she is trying to appear unreadable. That contradiction keeps the characterization alive. We can recognize the desire to be taken seriously while questioning what she does to secure that recognition.
The danger, for both the character and the viewer, is mistaking this effort for proof of substance. Seyfried makes the construction of the persona fascinating enough that we must keep reminding ourselves to look beyond it. The show becomes sharper whenever another character forces that shift.
The warning Elizabeth cannot afford to hear
Laurie Metcalf’s Phyllis Gardner supplies one of the drama’s clearest counterarguments: “You don’t get to skip any steps.” It is a memorable line because Elizabeth’s ambitions depend on shortening the distance between an idea and a finished achievement. Gardner insists that the intervening work has its own authority.
From Elizabeth’s perspective, skepticism threatens momentum. From Gardner’s, it is a necessary response to an inadequately developed proposal. The scene’s conflict comes from those incompatible understandings of criticism. One person hears an obstacle; the other is describing the work.
The series later gives that disagreement a concrete form when a malfunctioning prototype leads to a deceptive demonstration. A previous successful result is made to stand in for a functioning test. This is a decisive dramatic threshold. The problem has moved beyond confidence outrunning capability: an audience is being shown something designed to conceal the difference.
That distinction matters to the review’s moral reading. Ambition alone does not explain the deception. The scene involves a choice about what other people will be permitted to know. Elizabeth’s desire to preserve the company becomes inseparable from controlling the evidence available to its supporters.
Sunny Balwani and the narrowing of the room
Andrews gives Sunny a weight that changes the temperature around Seyfried’s Elizabeth. Their relationship joins personal attachment to the operation of the company, making reassurance and authority difficult to separate. The person who understands her ambitions also helps sustain a world in which those ambitions receive less effective challenge.
As the drama develops, the company’s increasingly restrictive atmosphere makes that partnership consequential for everyone outside it. Employees encounter boundaries around information, while doubts about the technology become threats to loyalty. A scientific disagreement acquires the emotional pressure of taking sides.
I find this more disturbing than a simple portrait of two domineering executives. The series shows how a shared project can become a closed conversation. Once protecting the enterprise means protecting the account its leaders give of it, correction starts to look like betrayal. That is a powerful mechanism for suspense because the audience can see how urgently the organization needs the questions it discourages.
The laboratory gives the drama its moral center
The story gains force when it follows people whose responsibilities cannot be satisfied by a persuasive presentation. Ian Gibbons, played by Stephen Fry, represents scientific expertise inside an organization increasingly resistant to its implications. His position exposes the difference between employing knowledgeable people and allowing their knowledge to govern decisions.
Erika Cheung and Tyler Shultz give that conflict another dimension. Their discovery of problems with testing brings the company’s grand claims down to the scale of individual results. The question becomes immediate: what should an employee do when the work contradicts the assurances surrounding it?
Tyler’s relationship with his grandfather, Theranos board member George Shultz, makes speaking up a test of family trust as well as professional judgment. The emotional obstacle is especially painful. Evidence does not arrive in a neutral room; it arrives among existing loyalties, reputations, and investments in being right.
Erika’s perspective helps widen the drama beyond that prominent family. Challenging an employer carries consequences for someone trying to establish a working life. Together, these characters make the stakes more tangible than another scene of Elizabeth winning attention. They turn the viewer’s interest toward the people who must act while powerful adults remain unconvinced.
What works—and where the series strains
The ensemble is both the show’s strength and its burden. Expanding beyond Elizabeth reveals the network that sustains her, but the movement among investors, executives, scientists, lawyers, and journalists can diffuse the emotional focus. Some explanatory exchanges feel arranged to carry information rather than emerge naturally from a relationship.
Still, the breadth serves a necessary purpose. A narrower character study could make Theranos appear to be the product of one unusual personality. The supporting perspectives show how different people can support the same enterprise for different reasons, without sharing the same knowledge or accepting the same risks.
This is where close attention to how film criticism weighs evidence is useful: the compelling performance and the convincing explanation are separate achievements. Seyfried supplies the former. The surrounding characters determine how fully the series achieves the latter.
Why the renewed attention matters
The current Holmes fascination gives The Dropout a fresh context, but viewers should resist treating the drama as a definitive answer to who she is. An actor can make a motive emotionally legible without proving that motive existed. The distinction also runs through our examination of what a screen portrait can reveal and leave unresolved.
The deeper achievement here is the depiction of responsibility being passed around. A founder asks for faith, a supporter supplies prestige, an employee postpones a confrontation, and each decision helps the next person continue. The suspense comes from watching that chain hold when it should break.
The Dropout is worth revisiting because it eventually redirects attention from the person everyone watches to the people few initially believe. Its most unsettling insight is that recognizing a performance is only the beginning. Someone still has to challenge it—and bear the consequences when the room would rather keep applauding.
Original content by this site's editorial team. Published: October 27, 2026 at 10:02:43 PDT (Los Angeles time)
